Medicines
General information about medicines, as well as advice on safety information, medicines and pregnancy, and medicine shortages.
More information
- Medicines
- How we regulate medicines
- Australia's medicine labels are becoming clearer
- Tamper-evident packaging
- PI/CMI search facility
- Medicines Repurposing Program - Eligibility criteria and prioritisation considerations
Dispose of unwanted medicines
Health professionals
University student education materials
Latest alerts
-
We have made a new Serious Scarcity Substitution Instrument to help manage the shortage and upcoming discontinuation of Ryzodeg 70/30 FlexTouch insulin.
-
We have been advised that Novo Nordisk will gradually discontinue some of its earlier generation insulin products over the next 2 years.
-
Shortage resolved
Latest articles
-
Updates to the Prescribing Medicines in Pregnancy database - September 2024
The Prescription Medicines in Pregnancy database has been updated to include new and amended entries. -
Product Information safety updates - September 2024
Information for health professionals about medicines with safety related updates to their product information. -
Therapeutic Goods (Poisons Standard) (Therapeutic Vaping Goods) Labelling Exemption 2024
This instrument is made under section 39 of the current Poisons Standard.
Events and webinars
Latest publications
-
Publication of the decisions made by a delegate of the Secretary in relation to glycopyrronium and palmitoylethanolamide.
-
Interim decisions on proposed amendments to the Poisons Standard closing 18 October 2024.
-
This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under regulation 42ZCZX of the Therapeutic Goods Regulations 1990, and the reasons for the decision.
Latest consultations
-
Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees.
-
We are seeking feedback on the proposed temporary labelling exemptions for paracetamol.
-
The TGA is seeking feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.